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Abstract
The Protein Ontology (PRO) provides terms for and supports annotation of species-specific
protein complexes in an ontology framework that relates them both to their components and
to species-independent families of complexes. Comprehensive curation of experimentally
known forms and annotations thereof is expected to expose discrepancies, differences, and
gaps in our knowledge. We have annotated the early events of innate immune signaling me-
diated by Toll-Like Receptor 3 and 4 complexes in human, mouse, and chicken. The result-
ing ontology and annotation data set has allowed us to identify species-specific gaps in
experimental data and possible functional differences between species, and to employ in-
ferred structural and functional relationships to suggest plausible resolutions of these dis-
crepancies and gaps.
Introduction
Diverse electronic databases now play central roles in storing, integrating, and analyzing infor-
mation relevant to human biology. UniProt maintains definitive catalogs of the properties of
human proteins and those of model organisms widely used in biomedical research [1]. Model
organism databases like the Mouse Genome Database generate comprehensive catalogs of
genes, functional RNAs and other genome features as well as heritable phenotypes, and curate
phenotype annotations including associations of model systems with human diseases [2]. Bio-
logical pathway resources like the Reactome Knowledgebase [3] record the molecular details of
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processes within the human organism. These processes, decomposed into reactions, yield a net-
work of molecular transformations that is an extended version of a classic metabolic map.
Pathways identify routes connecting proteins and small molecules within the map.
Reactome and other pathway resources are rich sources of complex information curated by
experts and stored in data structures developed to meet the needs of their core user communi-
ties. This richness and specialization, however, is also a limitation. The unique organization of
each resource makes attempts to integrate and analyze data across resources difficult. Biomedi-
cal ontologies provide tools that can address these problems. These ontologies provide rigor-
ous, unambiguous descriptions of biological objects and of the relationships among them using
standardized and well-understood formats. Ontology structures enable the development of
powerful computational tools that can reliably integrate and through both rational and statisti-
cal methods analyze the large, diverse sets of experimental data curated by independent groups
of experts and stored in independent electronic databases. Within the OBO Foundry model,
ontologies have been developed to describe orthogonal features of biology, but to a common
standard to ensure interoperability [4]. Such ontologies link diverse structural and functional
annotations into a single, coherent logical frame. Reasoning tools can identify discrepancies in
represented data and suggest plausible attributes for entities that have not been experimentally
studied.
GO, the Gene Ontology [5, 6], provides structured controlled vocabularies of biological
terms that describe the molecular functions of gene products, their roles in biological processes,
and their organization into cellular components. PRO, the Protein Ontology [7–10], captures
the gene products themselves, including evolutionary families of proteins and, within each
family, canonical and modified forms of proteins (“proteoforms”), the complexes they form,
and their relationships. These PRO annotations link canonical species-independent forms of
these entities to species-specific forms and variants.
In this work, we propose that PRO can aid the integration of disparate data and enable bio-
logically sound inferences. As a proof-of-concept, we analyzed innate immune signaling data
from different organisms (human, chicken and mouse) and sources (Reactome and Center for
Computational Immunology). We studied whether Reactome’s annotations for human and
chicken proteins and complexes involved in innate immune signaling [11] can be imported
into formal annotations of proteins and complexes in PRO in a way that supports inferences of
complex formation, subcellular localization, and roles in biological processes for corresponding
mouse proteins catalogued by the Center for Computational Immunology [12].
The innate immune systems of humans and mice have both been extensively characterized
so this exercise has allowed us to test the reliability of annotations in one species for predicting
complex formation, subcellular location, and function in the other, and to identify true differ-
ences in the signaling processes between the two species. Where experimental data exist only
for one species, we have asked whether the PRO evolutionary family framework supports plau-
sible inferences to fill gaps.
The innate immune signaling system
The innate immune system is an evolutionarily ancient signaling mechanism that provides an
initial defense against invading microorganisms. Pattern recognition receptors (PRRs) express-
ed either on the cell surface or in the cytoplasm recognize microbe-associated molecular pat-
terns (MAMPs) [13–15]. MAMP binding to a PRR triggers a signaling cascade that can result
in the production of cytokines and other molecules that mediate inflammation. Several well-
conserved PRR families have been identified [16]. Of these, the TLR family is the best charac-
terized in terms of known ligands and downstream signaling pathways [17–20]. The first
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member of the Toll gene family was identified in Drosophila and shown to play a role in embry-
onic dorsal-ventral patterning [21]. The Drosophila Toll gene family was later shown to be crit-
ical for anti-fungal and antibacterial responses [22, 23]. Homologs of the Drosophila Toll
protein have been identified in many other species.
TLR Protein Family
The TLR protein family (PRO PR_000001096) contains six subfamilies with distinct ligand
specificities and signaling properties [12, 24, 25]. Despite a wide range of ligands, TLRs share
common structural features: a large extracellular domain (ECD), a transmembrane domain
and a cytoplasmic Toll/Interleukin 1 receptor (TIR) domain. The ECD in turn consists of a
varying number of leucine-rich repeats (LRR) and is responsible for MAMP recognition. The
TIR domain (Pfam PF01582) interacts with downstream proteins when the ECD is activated
by MAMP binding. Phylogenetic analysis of ECDs suggests that these sequences have evolved
relatively rapidly in a process driven by the positive selection imposed by changing microor-
ganisms, while TIR domains have evolved more slowly under purifying selection. TIR domains
appear to have co-evolved with the intracellular adaptor molecules with which they interact
[12].
For this study, we have focused on initial steps of the signaling cascades initiated by interac-
tions of the well-studied TLR3 and TLR4 receptors with their ligands (Fig 1). These receptors
share common steps in the signaling cascade but are distinct in complex composition and the
initial steps of signaling. TLR3 is associated with endosomal membranes and is implicated in
the recognition of intracellular viral dsRNA. TLR4 is associated with the plasma membrane
and is predominantly activated by extracellular lipopolysaccharide (LPS) derived from bacteria.
Both TLR3 and TLR4 utilize TIR-domain-containing adapter-inducing interferon-β (TRIF) to
signal from the endosomal compartment. TRIF-mediated signaling is essential for IFN regula-
tory factor (IRF)-dependent production of type I IFN. While TLR3 signals exclusively through
adaptor TRIF, TLR4 can also utilize myeloid differentiation primary response 88 protein
(MyD88) from its plasma membrane location. The MyD88-dependent pathway is shared by all
TLR receptors except TLR3, leading to production of proinflammatory cytokines.
Methods
PRO captures continuant properties of proteins and protein complexes such as the covalent
modifications that differentiate the modified forms of a protein from one another and the
Fig 1. Signaling cascades initiated by ligand binding by TLR3 and TLR4 in human (left) andmouse
(right). Proteins are shown as colored shapes, LPS as a cluster of open circles, and dsRNA as intertwined
black lines. Entities and interactions for which there is not consistent evidence of conservation between
species are shown as dotted outlines in the species for which there is no evidence for their function.
doi:10.1371/journal.pone.0122978.g001
Integrated Protein Ontology Framework for TLR Complexes
PLOS ONE | DOI:10.1371/journal.pone.0122978 April 20, 2015 3 / 12
identities and numbers of copies of the components of a protein complex [7, 8]. To describe
the roles of proteins and complexes in the biological transformations that make up a pathway,
however, it is also necessary to capture their occurent properties: molecular functions which
these proteins exercise, the biological processes in which they participate and the subcellular lo-
cations which they may occupy.
Previous work within the Reactome project [11] and under the auspices of the Center for
Computational Immunology [12, 26] has yielded catalogs of human, mouse, and chicken pro-
teins and complexes involved in TLR signaling. Reactome annotations have also associated
functions and subcellular locations with these proteins. PRO terms have been generated for en-
tries in these catalogs and they have been cross-referenced to entries in Reactome, to the canon-
ical forms of proteins in UniProt, and to entries for small molecules in CHEBI [27]. Annotated
reactions and associated input and output physical entities are compiled in the supporting in-
formation associated with this paper (S1 Table); PRO, Reactome, UniProt and CHEBI terms
for physical entities are shown in Tables 1 and 2.
Both Reactome and the Center for Computational Immunology provided tab-delimited files
of complexes, components and functional annotations which were used as the starting point to
create PRO terms for complexes. A PRO curator reviewed the evidence for the complexes and
their components and also aligned the equivalent complexes between human, mouse and
chicken. The PRO curator also i) mapped the complexes to the most appropriate GO protein
complex term as a parent, or created PRO complex terms to link the complexes when needed;
and ii) added PRO terms for all the complex components when these were not in the ontology.
The details of the curation protocol used in this work are available online [28]. Any discrepancy
Table 1. TLR3 and TLR4 complexes.
parent PRO ID name human PRO ID human Reactome ID mouse PRO ID
PR:000037302 viral dsRNA:TLR3 complex PR:000037303 REACT_7159 PR:000037304
PR:000037306 ticam1:viral dsRNA:TLR3 complex PR:000037307 REACT_7381 PR:000037308
PR:000037309 traf3:ticam1:activated TLR3 complex PR:000037310 REACT_124037 PR:000037311
PR:000037343 traf6:ticam1:activated TLR3 complex PR:000037344 REACT_25948 PR:000037471
PR:000036003 MD2:TLR4 complex PR:000036004 REACT_7105 PR:000036005
PR:000036076 MD2:LPS:TLR4 complex none none PR:000036077
PR:000025497 lipopolysaccharide receptor complex 3 PR:000025773 REACT_124771 PR:000037476
PR:000025498 lipopolysaccharide receptor complex 4 PR:000037479 REACT_124771 none
PR:000027202 ticam2:activated TLR4 complex PR:000028678 REACT_7083 PR:000027204
PR:000027205 ticam1:ticam2:activated TLR4 complex PR:000027208 REACT_7861 PR:000027207
PR:000028681 traf3:ticam1:ticam2:activated TLR4 complex PR:000036022 REACT_124037 PR:000028683
PR:000028679 traf6:ticam1:ticam2:activated TLR4 complex PR:000028680 REACT_25948 PR:000035710
PR:000036078 TIRAP:PIP2:activated TLR4 complex PR:000036135 REACT_152404 PR:000027196
PR:000037472 TIRAP:PIP2:BTK:activated TLR4 complex PR:000037447 REACT_124673 PR:000037477+
PR:000037472 pTIRAP:PIP2:BTK:activated TLR4 complex PR:000037448 REACT_125282 PR:000027217
PR:000037488 MyD88:TIRAP:PIP2:BTK:activated TLR4 complex PR:000037446 REACT_7694 PR:000037481+
PR:000025784 MyD88:Mal:activated TLR4 receptor none none PR:000027174
+ All PRO annotations are based on experimental evidence (Evidence code ontology ECO:0000269) except ones marked with asterisks, which are based
on reconstruction of a biological system (ECO:0000088)
For each complex involved in the initial steps of TLR3 or TLR4 signaling (Table 1), the PRO identiﬁer of its species-agnostic form (parent PRO ID) is
listed, together with its PRO name and the PRO identiﬁers of its human and mouse forms and the Reactome identiﬁer of its human form. A version of this
table with hyperlinks to the databases embedded in each identiﬁer is available in S2 Table.
doi:10.1371/journal.pone.0122978.t001
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was reported back to the groups, re-evaluated, and resolved. The final content in PRO for the
TLR set has been agreed between the different parties.
To annotate GO molecular function, biological process, and cellular location properties of
these proteins and complexes in the PRO framework, we have also used relations from the
OBO Foundry Relation Ontology (RO) [29, 30] in the PRO framework [7–9].
Function
To annotate functions of instances of proteins and complexes we associate PRO terms for these
entities and GO terms for molecular functions with the RO relation has_function. For example:











none dsRNA CHEBI:67208 none CHEBI:67208 None
none lipopolysaccharide CHEBI:16412 none CHEBI:16412 None
none 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate CHEBI:18348 none CHEBI:18348 None
PR:000025492 Toll-like receptor 4 isoform 1, signal peptide
removed glycosylated 1
O00206-1 PR:000025787 Q9QUK6-1 PR:000027172
PR:000018357 Toll-like receptor 3, signal peptide removed form O15455 PR:000037305 Q99MB1 PR:Q99MB1
PR:000003299 lymphocyte antigen 96 isoform 1, signal peptide
removed, glycosylated 1
Q9Y6Y9-1 PR:000025786 Q9JHF9-1 PR:000027171
PR:000001749 TIR domain-containing adapter molecule 1
(TICAM1)
Q8IUC6 PR:Q8IUC6 Q80UF7 PR:Q80UF7
PR:000002289 TNF receptor-associated factor 3 (TRAF3) Q13114 PR:Q13114 Q60803 PR:Q60803
PR:000002292 TNF receptor-associated factor 6 Q9Y4K3 PR:Q9Y4K3 P70196 PR:P70196
PR:000001750 TIR domain-containing adapter molecule 2 Q86XR7 PR:Q86XR7 Q8BJQ4 PR:Q8BJQ4
PR:000001740 myeloid differentiation primary response protein
MyD88
Q99836 PR:Q99836 P22366-1 PR:000025766
PR:000024846 myeloid differentiation primary response protein
MyD88 isoform 2
none none P22366-2 PR:000025767
PR:000001751 Toll/interleukin-1 receptor domain-containing
adapter protein
P58753 PR:P58753 Q99JY1 PR:Q99JY1
PR:000027213 Toll/interleukin-1 receptor domain-containing
adapter protein phosphorylated form
P58753 PR:000027214 none None
For each of the three nonprotein molecules involved in forming TLR3 and TLR4 complexes, its name and identiﬁer in the ChEBI reference database is
given. For each of the proteins involved in these complexes, PRO name and the UniProt and PRO identiﬁers for its mouse and human forms are given. A
version of this table with hyperlinks to the databases embedded in each identiﬁer is available as S3 Table.
doi:10.1371/journal.pone.0122978.t002
Fig 2. PRO stanzas illustrating the annotation of occurent properties of proteins and complexes. A,
function;B, biological process;C, location. Stanzas are in PAF format as described previously [7]; phrases to
capture function, process, and location annotations are highlighted in red.
doi:10.1371/journal.pone.0122978.g002
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CD14 (PR:000035703) has_function LPS binding (GO:0001530);
Generalizing,
Entity1PRO has_function GO:#######GO
where Entity1 is a protein or complex annotated in PRO and GO:####### is a molecular func-
tion term defined in GO.
This assertion is incorporated into the PRO PAF entry for a modified CD14 isoform as
shown in Fig 2A.
Instances of complexes are annotated in the same way as individual proteins. For example:
IRF7-P:IRF7-P complex (human) (PR:000027086) has_function sequence-specific DNA
binding transcription factor activity (GO:0003700).
Here and below, complexes are named by listing their constituent proteins separated by colons
[31].
In addition, the PRO framework enables representation of molecular functions of compo-
nents of a complex having distinct roles within the complex by creation of a term for the sub-
type of protein that is part of such a complex,
Complex1PRO has_component Protein1PRO AND Protein1PRO has_function GO:
#######GO
Process
To annotate the involvement of instances of TLR proteins and complexes in signaling process-
es, PRO terms for entities are associated with GO biological process terms with the RO relation
participates_in. For example (Fig 2B),
traf6:ticam1:activated TLR3 complex (human) (PR:000037344) participates_in MyD88-in-
dependent toll-like receptor signaling pathway (GO:0002756)
Location
Cellular localization is annotated by relating the PRO term for a physical entity to a GO cellular
component term. For example (Fig 2C),
IRF7 unphosphorylated 1 (PR:000037791) located_in cytoplasm (GO:0005737). Similarly,
IRF7-P:IRF7-P complex (human) (PR:000027086) located_in nucleoplasm (GO:0005654).
While this is an ontological assertion about a cellular entity rather than about a protein type,
inclusion of this assertion allows the ontology to be queried to identify the cellular compart-
ment or compartments in which a process occurs.
We then use the RO relations has_component and has_part, already implemented in
PRO, to form triples that relate macromolecular complexes to their component proteins and
to relate proteins with their domains, respectively. For example, ticam1:viral dsRNA:TLR3
complex (mouse) (PR:000037308) has_component PR:Q80UF7 {cardinality = "2"}! TIR
Integrated Protein Ontology Framework for TLR Complexes
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domain-containing adapter molecule 1 (mouse) [complex:protein], and Toll-like receptor
(PR:000001096) has_part TIR domain (PF01582) [protein:domain].
The PRO terms and annotations related to this paper have been collected in a separate set of
TLR-specific files, available via FTP [32]. All terms and annotations are also part of PRO re-
lease 43 and later.
The organization and content of the PRO annotation file (PAF) have been described previ-
ously [7]. Briefly, the PAF shows the annotation of PRO entities using GO or other ontologies,
and adopts the format of the GO annotation file with some modifications. The PAF annota-
tions connect PRO terms to terms from these ontologies and include the corresponding rela-
tion. Additional columns account for sequence coordinate specifications, such as the range of
the sequence (for cleaved forms) or sites of covalently modified residue(s). In addition to the
qualifiers used by GO (like NOT), the PAF introduces the qualifiers increased and decreased,
along with a column to indicate what the object of comparison is. PAF documentation is avail-
able [33].
Results and Discussion
Here we describe strategies to integrate PRO annotations for complexes [8] with functional an-
notations derived from pathway databases like Reactome and other resources, focusing on the
initial steps of the TLR3 and TLR4 signaling pathways in human, mouse, and chicken.
TLR3 and TLR4 together represent key signaling strategies used by Toll receptors to initiate
reactions of innate immunity. TLR4 is unique in that upon activation it recruits adaptor mole-
cules for both MyD88-dependent and MyD88-independent signaling. TLR3 specifically uses
the TRIF-signaling pathway but without the use of TRAM (Fig 1) [34]. All other TLRs activate
MyD88-dependent signaling only.
Experimental studies of chicken, mouse and human systems have established that in all
three species the TLR3-mediated signaling pathway is triggered by recognition of viral dsRNA
and the TLR4-mediated signaling pathway is triggered by recognition of bacteria-derived LPS
[35, 36]. The initial pathway steps in which a TLR receptor binds its ligand and then interacts
via its cytosolic domain with its first downstream target have been annotated (S1 Table). Many
of the annotations of individual proteins and complexes (Tables 1 and 2) are based on experi-
mental observations; the rest are inferences based on relationships between the experimentally
characterized proteins and their uncharacterized but structurally similar orthologues. In the
course of this work, 603 new PRO terms were created, 20 for families, 64 for genes, 110 for or-
ganism-specific forms of genes, 69 for covalent modifications, 42 for organism-specific cova-
lent modifications, 48 for GO complexes, 109 for PRO complexes, 119 for organism-specific
PRO complexes, and 50 with Reactome cross-references.
In vertebrates the sensing of LPS involves transfer of LPS monomers to CD14 mediated by
the LPS-binding protein (LBP). CD14 in turn commonly delivers the LPS to a complex of mye-
loid differentiation protein-2 (MD2) and TLR4 which transduces the signal through the re-
cruitment of adaptor proteins to the TIR domain of TLR4 [34, 37]. There are three versions of
the LPS:CD14 complex, namely GPI-anchored CD14:LPS, soluble CD14:LPS and transmem-
brane CD14:LPS (Fig 3). Each of these complexes features a distinct form of CD14. Mammals
express two of these forms, soluble and GPI-anchored, whereas in birds only a complex with
the transmembrane version of CD14 has been identified to date [38].
Downstream signaling complexes such as the MD2:TLR4 complex show another interesting
difference between taxa. Whereas the mammalian version participates in both the MYD88-de-
pendent and independent signaling pathways, the chicken version may only be able to partici-
pate in the MYD88-dependent pathway [34, 39]. This functional difference is captured in PRO
Integrated Protein Ontology Framework for TLR Complexes
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annotations as shown in Table 3, illustrating the use of PRO annotations as a tool for
making discoveries.
Comparison of the PRO annotations for mouse and human CD14 complexes identified a
potentially significant gap in our understanding of CD14 function (Table 1; Fig 1). In well-
studied mouse and human systems, CD14 binds LPS and brings it in close proximity to the
TLR4:MD2 complex allowing the recognition of LPS by MD2 and TLR4. Data from mouse
cells, however, suggest that CD14 may be dispensable for the downstream events [40–42] while
data from human cells suggest that CD14 is translocated to the endosomal compartment in as-
sociation with the TLR4 receptor complex [43–45], thus arguing that CD14 may be required
for downstream TLR4 signaling events.
Although ligand binding and transfer by CD14 has been extensively studied by mutagenesis
and epitope mapping of blocking antibodies in both human and animal models [40, 41,
46–49], the molecular mechanism behind CD14 interaction with the receptor complex remains
elusive. Mechanisms for ligand-induced endocytosis of CD14 and control of endosomal traf-
ficking of the TLR receptor complex likewise remain unclear.
Further we found that mouse complexes containing MyD88 protein are represented in two
forms, containing alternatively spliced long and short isoforms of MyD88, MyD88l and
MyD88s (Tables 1 and 2). The long or canonical form of MyD88 protein is a bipartite domain
adaptor molecule composed of an amino-terminal death domain and a carboxyl-terminal TIR
domain. MyD88l bridges interleukin-1 receptor-associated kinase 4 (IRAK4) to the TIR-
domain of receptor signaling complex. The short formMyD88s lacks the region between the
death domain and the TIR domain. MyD88s is also recruited to the TIR-domain of TLR4 re-
ceptor complex but it blocks NFkappaB induction because it fails to activate IRAK4 in mouse
cells [50, 51]. In contrast, although human cells have been reported to express MyD88s, only
TLR4 complexes involving the canonical long form of MyD88 have been observed. This
Fig 3. Cytoscape views of the LPS:CD14 complex repertoire. Nodes are physical entities. Circles denote
proteins, triangles denote other molecules, and squares denote complexes. Dashed edges denote
has_component relationships between entities; solid ones denote is_a relationships between specific and
generic forms of entities.
doi:10.1371/journal.pone.0122978.g003
Table 3. Annotation of species-specific functions of MD2:TLR4 complexes.
MD2:TLR4 complex Annotation Evidence
Mouse PR:000036005 participates_in Toll-like receptor 4 signaling pathway (GO:0034142) [52]
Human PR:000036004 participates_in Toll-like receptor 4 signaling pathway (GO:0034142) REACT_6894
Chicken PR:000037473 NOT participates_in MyD88-independent toll-like receptor signaling pathway (GO:0002756) [34,39] REACT_25089
A version of this table with hyperlinks to the databases embedded in each identiﬁer is available as S4 Table.
doi:10.1371/journal.pone.0122978.t003
Integrated Protein Ontology Framework for TLR Complexes
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difference is consistent with the lack of evidence showing that LPS-induced activity of MyD88s
inhibits MyD88-mediated TLR4 pathway in human cells.
A key feature of the work described in this paper is that it involves the annotation of specific
instances of physical entities: the collections of molecules in particular cells occupy a subcellu-
lar location or exhibit a function. Work now underway on development of a formal ontology
for these classes and relationships will enable us to use these annotations as the basis for asser-
tions to support automated reasoning. While the expert manual annotation process does not
scale well, it does provide a large body of validated data that will provide a rigorous test of auto-
mated reasoning tools.
Conclusion
We have described an annotation process that integrates PRO ontology terms for protein com-
plexes with GO terms for molecular function, biological process, and cellular component. The
resulting annotations are explicitly tagged to indicate their basis in experimental data or in
manually verified inferences based on sequence similarity among proteins. The results high-
light similarities and differences between signaling processes mediated by two members of the
TLR family, TLR3 and TLR4, and among three vertebrate species, human, mouse, and chicken.
This annotation strategy is readily extended to the large data sets in pathway databases like
Reactome and with the continued development of ontologies and reasoning tools should allow
these resources to be mined efficiently and reliably, to discover putative novel functional rela-
tionships among proteins and protein complexes and to critically assess their plausibility.
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